T1	Pharmacological_substance 55 66	risperidone
N1000 	Reference T1 MeSH:D018967	risperidone
T2	Disorder 87 100	schizophrenia
N1 	Reference T2 UMLS:C0036341	schizophrenia
T3	Disorder 130 143	schizophrenia
N2 	Reference T3 UMLS:C0036341	schizophrenia
T4	Pharmacological_substance 189 200	risperidone
N1001 	Reference T4 MeSH:D018967	risperidone
T5	Disorder 331 341	depression
N3 	Reference T5 UMLS:C0011570	depression
N4 	Reference T5 UMLS:C0011581	depression
T6	Disorder 368 376	insomnia
N5 	Reference T6 UMLS:C0917801	insomnia
T7	Pharmacological_substance 721 732	risperidone
N1002 	Reference T7 MeSH:D018967	risperidone
T8	Disorder 770 783	schizophrenia
N6 	Reference T8 UMLS:C0036341	schizophrenia
T9	Disorder 830 837	anxiety
N7 	Reference T9 UMLS:C0003469	anxiety
T10	Subject 73 81	patients
T11	Subject 103 124	Six of 13 outpatients
T16	Disorder 346 363	periods of crying
N8 	Reference T16 UMLS:C0009443	periods of crying
N9 	Reference T16 UMLS:C0024117	periods of crying
T17	Disorder 305 326	feelings of agitation
N10 	Reference T17 UMLS:C0085631	feelings of agitation
T20	Disorder 275 293	intolerable affect
T26	Subject 756 764	patients
T27	Subject 793 806	some patients
T28	Speculation_cue 839 842	may
